GLASGOW – Uvax Bio, an early-stage vaccine technology company, is planning an $8 million expansion of its research and production work in Delaware, building out a lab and hiring dozens […]
© 2022 Delaware Business Times
Holiday flash sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.